Yimin Cui

Title: Yimin Cui: Innovator in Anti-Cancer Compounds

Introduction

Yimin Cui is a prominent inventor based in Beijing, China. He has made significant contributions to the field of pharmaceutical research, particularly in the development of anti-cancer compounds. His innovative work has the potential to impact cancer treatment significantly.

Latest Patents

Yimin Cui holds a patent for an indazole hydrazide compound and its applications. This compound, represented in formula (I), features R selected from substituted alkyl, substituted alkenyl, and substituted phenyl. The substituents in the substituted alkyl and substituted alkenyl include phenyl and/or substituted phenyl, while R′ can be H or alkyl. Compared to prior art, this indole hydrazide compound serves as an integrin avβ3 receptor antagonist. It exhibits notable anti-prostate cancer activity and demonstrates a significant inhibitory effect on enzalutamide-resistant cell lines. Furthermore, this compound has pronounced anti-tumor angiogenesis activity and can be utilized in the preparation of anti-tumor angiogenesis drugs to inhibit tumor angiogenesis. Yimin Cui has 1 patent to his name.

Career Highlights

Yimin Cui is currently employed at Beijing Baheal Chengchuang Pharmaceutical Research and Development Co., Ltd. His work at this company focuses on advancing pharmaceutical innovations that target critical health issues, particularly cancer.

Collaborations

Yimin Cui collaborates with notable colleagues, including Xiaocong Pang and Xu He. Their combined expertise contributes to the success of their research initiatives.

Conclusion

Yimin Cui is a dedicated inventor whose work in developing anti-cancer compounds showcases his commitment to advancing medical science. His contributions have the potential to lead to significant breakthroughs in cancer treatment.